Mason & Associates (California)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$634K Sell
2,668
-415
-13% -$86.2K 0.1% 106
2026
Q1
$636K Sell
3,083
-156
-5% -$33.6K 0.12% 96
2025
Q4
$666K Buy
3,239
+1,736
+116% +$327K 0.13% 91
2025
Q3
$236K Sell
1,503
-290
-16% -$44.8K 0.05% 120
2025
Q2
$301K Sell
1,793
-42
-2% -$6.23K 0.07% 99
2025
Q1
$253K Hold
1,835
0.06% 98
2024
Q4
$217K Hold
1,835
0.05% 101
2024
Q3
$203K Buy
+1,835
New +$192K 0.05% 107
2024
Q2
Sell
-1,835
Closed -$205K 108
2024
Q1
$205K Buy
+1,835
New +$198K 0.05% 109

Other funds holding CAH

Mason & Associates (California)'s CAH Position: Q2 2026 in Review

Mason & Associates (California) reduced its Cardinal Health (CAH) stake by 13% in Q2 2026, selling an estimated $86.2K and leaving 2,668 shares worth $634K. The position accounts for 0.1% of the portfolio, ranked #106.

Mason & Associates (California) first reported a position in CAH in Q1 2024 and has held it in 9 quarters since. The position peaked at $666K in Q4 2025. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Mason & Associates (California) held 2,668 shares of Cardinal Health worth $634K as of Q2 2026.
  • Mason & Associates (California) sold 415 Cardinal Health shares in Q2 2026, an estimated $86.2K.
  • Cardinal Health made up 0.1% of Mason & Associates (California)'s portfolio in Q2 2026, its #106 holding.
  • Mason & Associates (California) first reported a position in Cardinal Health in Q1 2024 and has held it in 9 quarters since.
  • Mason & Associates (California)'s Cardinal Health position peaked at $666K in Q4 2025.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Mason & Associates (California)'s 13F filing for Q2 2026, filed 23 Jul 2026.